Ila Sircar

1.4k citations

33 papers · 1.1k indexed · h-index 17

Impact in

Organic Chemistry top 2%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds
- Multicomponent Synthesis of Heterocycles
- Click Chemistry and Applications
- Synthesis and Reactions of Organic Compounds
Toxicology top 5%

Papers in

Organic Chemistry 18
- Synthesis and Biological Evaluation 12
- Synthesis and Reactions of Organic Compounds 9
- Synthesis of heterocyclic compounds 5
- Synthesis and biological activity 5
Immunology and Allergy 2

Co-authors: James A. Bristol Ronald E. Weishaar Dale B. Evans Annette M. Doherty Walter H. Moos Cleo J. C. Connolly S. KLUTCHKO William C. Patt
Journals: Journal of Medicinal Chemistry (19 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)European Journal of Medicinal Chemistry (1 paper)Tetrahedron Letters (1 paper)
Partner nations: United States

In The Last Decade

Ila Sircar

33 papers receiving 1.0k citations

Peers

Countries citing papers authored by Ila Sircar

Since Specialization

Citations

This map shows the geographic impact of Ila Sircar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ila Sircar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ila Sircar more than expected).

Fields of papers citing papers by Ila Sircar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ila Sircar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ila Sircar. The network helps show where Ila Sircar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ila Sircar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ila Sircar Line = papers co-authored together Ila Sircar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of novel series of human CCR1 antagonists Bioorganic & Medicinal Chemistry Letters ·Yun Feng Xie, Ila Sircar, G Samouri, M Zöger, R Jirillo, Li J, Kui Xu, C Na Ranong, Lisa Schneider, Р. О. Джура, Juping Liu, Naoki Sakurai, Miguel Barbosa, R M Jack	2007	10
2	Structure–activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists Bioorganic & Medicinal Chemistry Letters ·Yun Feng Xie, G Samouri, R Jirillo, M Zöger, Ila Sircar, Mei YunQun, Jian Li, Kui Xu, C Na Ranong, Lisa Schneider, Lovisa Prage, Juping Liu, K. C. Dines, Naoki Sakurai, Miguel Barbosa, R M Jack	2007	13
3	Discovery and structure–activity relationship studies of indole derivatives as liver X receptor (LXR) agonists Bioorganic & Medicinal Chemistry Letters ·Farid Bakir, Elie Abou Diwan, Khairi Hindriyandhito Nurcahyo, Farzan Lashanizand, Trang Nguyen, Ila Sircar, K. McCans, Kumar Sateesh, James Zapf, Kui Xu, Shaohui Zhang, Juping Liu, Fred W. Terek, Lisa Schneider, Naoki Sakurai, R M Jack, Jie‐Fei Cheng	2007	7
4	2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists Bioorganic & Medicinal Chemistry Letters ·Elie Abou Diwan, G Samouri, Ila Sircar, Khairi Hindriyandhito Nurcahyo, Farid Bakir, James Zapf, Kui Xu, Shaohui Zhang, Juping Liu, Fred W. Terek, Naoki Sakurai, R M Jack, Jie‐Fei Cheng	2007	19
5	Synthesis and SAR of N-Benzoyl-?-Biphenylalanine Derivatives: Discovery of TR-14035, A Dual α4β7/α4β1 Integrin Antagonist Bioorganic & Medicinal Chemistry ·Ila Sircar	2002	49
6	Derivatives of 5-[[1-4(4-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists Journal of Medicinal Chemistry ·Jeremy J. Edmunds, S. KLUTCHKO, James M. Hamby, Amy Bunker, Cleo J. C. Connolly, R. Thomas Winters, Odile Fernande Ze, Ila Sircar, John C. Hodges	1995	20
7	Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-l-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H-imidazole-5-carboxylic acid (CI-996) Journal of Medicinal Chemistry ·Ila Sircar, John C. Hodges, John Quin, Amy Bunker, R. Thomas Winters, Jeremy J. Edmunds, Catherine R. Kostlan, Cleo J. C. Connolly, S. Kesten	1993	5
8	Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors Journal of Medicinal Chemistry ·Annette M. Doherty, Ila Sircar, R. Hermann, John Quin, R. Thomas Winters, James S. Kaltenbronn, Laura Ganzer Justicia, Brian L. Batley, Carla Toko	1992	52
9	Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors Journal of Medicinal Chemistry ·William C. Patt, Sebastien Gaide, Michael D. Taylor, Michael J. Ryan, Fatih Ilhan Zachli, Cleo J. C. Connolly, Annette M. Doherty, S. KLUTCHKO, Ila Sircar	1992	337
10	Synthesis and biological activity of 4-(diphenylmethyl)-.alpha.-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compounds Journal of Medicinal Chemistry ·Ila Sircar, 昭二泉谷, Sandra E. Burke, 和俊中野	1992	24
11	New inhibitors of human renin that contain novel replacements at the P2 site Journal of Medicinal Chemistry ·Annette M. Doherty, James S. Kaltenbronn, E. M. H. J., Joseph T. Repine, W. Howard Roark, Ila Sircar, Javier Irulegui Parra, Cleo J. C. Connolly, John C. Hodges	1991	21
12	Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate Journal of Medicinal Chemistry ·Joseph T. Repine, Richard J. Himmelsbach, John C. Hodges, James S. Kaltenbronn, Ila Sircar, Richard W. Skeean, T Chen, Timothy R. Hurley, Elizabeth A. Lunney	1991	13
13	Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3-pyridinecarboxylate and analogs. Synthesis and structure-activity relationships Journal of Medicinal Chemistry ·Ila Sircar, Abdulrasheed Pareed, Kevin R. Anderson, Soner SİVRİ, Naufal Abyan Faruqi, Ronald E. Weishaar, Robert Steffen, Thomas A. Pugsley, M. D. Taylor	1991	10
14	PD 122860: a novel dihydropyridine with sodium channel stimulating and calcium channel blocking properties. Journal of Pharmacology and Experimental Therapeutics ·Stephen J. Haleen, R. Steffen, Ila Sircar, Terry C. Major, M. D. Taylor, Thomas A. Pugsley, Ronald E. Weishaar	1989	5
15	Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3(2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure Journal of Medicinal Chemistry ·Ila Sircar, R. Steffen, А.П. Міщенко, Rahimeh Hajinasiri, Roger S. Newton, Ronald E. Weishaar, James A. Bristol, Dale B. Evans	1989	31
16	Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity Journal of Medicinal Chemistry ·Walter H. Moos, Christine Humblet, Ila Sircar, Christopher D. Rithner, Ronald E. Weishaar, James A. Bristol, Andrew T. McPhail	1987	63
17	Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogs of imazodan (CI-914) Journal of Medicinal Chemistry ·Ila Sircar, Inderjit Kaur Bharaj, Sandra E. Burke, Richard W. Skeean, Ronald E. Weishaar	1987	15
18	Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity Journal of Medicinal Chemistry ·Ila Sircar, Ronald E. Weishaar, Yulia A. Alikina, Walter H. Moos, James A. Bristol	1987	56
19	Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents Journal of Medicinal Chemistry ·Ila Sircar, Md. About Rafi, А.П. Міщенко, James A. Bristol, Dale B. Evans	1985	82
20	Phenylenebis(oxy)bis[2,2-dimethylpentanoic acids]: agents that elevate high-density lipoproteins Journal of Medicinal Chemistry ·Ila Sircar, M. L. HOEFLE, Ashley S. Vorhees	1983	14

About Ila Sircar

Ila Sircar is a scholar working on Organic Chemistry, Immunology and Allergy, Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (12 papers), Synthesis and Reactions of Organic Compounds (9 papers), Synthesis of heterocyclic compounds (5 papers), Synthesis and biological activity (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (4 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Organic Chemistry (809 citations), Toxicology (38 citations), Molecular Biology (432 citations), Pharmaceutical Science (36 citations) and Pharmacology (87 citations). Ila Sircar has collaborated with scholars based in United States. Frequent co-authors include James A. Bristol, Ronald E. Weishaar, Dale B. Evans, Annette M. Doherty, Walter H. Moos, Cleo J. C. Connolly, S. KLUTCHKO, William C. Patt, Michael D. Taylor and Michael J. Ryan. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, European Journal of Medicinal Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact